Skip to main content

Table 6 OHSS events and severity

From: A comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE study

 

Study group

(N = 1783)

Control group

(N = 1419)

OHSS events, n (%)

P-valuea

27 (1.5)

57 (4.0)

P < 0.0001

OHSS severity, n (%)

Mild/Grade I

Moderate/Grade II

Severe/Grade III

12 (0.7)

13 (0.7)

2 (0.1)

32 (2.3)

20 (1.4)

5 (0.4)

  1. OHSS ovarian hyperstimulation syndrome
  2. aChi square test was used to calculate the p-value